For most of the drugs advantages of taking medications overweighs the potential risks however some drugs could be really dangerous for breastfed baby hence every medication shall be considered separately. In this page we will discuss about purpose of Tobramycin Inhalation Solution Pak | Tobramycin Solution and its risk associated with lactation. We will also discuss the usage of Tobramycin Inhalation Solution Pak | Tobramycin Solution and some common side effects associated with Tobramycin Inhalation Solution Pak | Tobramycin Solution.
What is Tobramycin Inhalation Solution Pak | Tobramycin Solution used for?
1. INDICATIONS AND USAGE TOBRAMYCIN INHALATION SOLUTION PAK (co-packaging of tobramycin inhalation solution and PARI LC PLUS Reusable Nebulizer) is indicated for the management of cystic fibrosis in adults and pediatric patients 6 years of age and older with P. aeruginosa. Safety and efficacy have not been demonstrated in patients under the age of 6 years, patients with FEV1 <25% or >75% predicted, or patients colonized with Burkholderia cepacia [see Clinical Studies (14)]. TOBRAMYCIN INHALATION SOLUTION PAK contains tobramycin, an aminoglycoside antibacterial drug indicated for the management of cystic fibrosis in adults and pediatric patients 6 years of age and older with Pseudomonas aeruginosa (1).
Is Tobramycin Inhalation Solution Pak | Tobramycin Solution safe to use while breastfeeding? Can it interfere with growth and development of my kid?
Tobramycin is the only one ingredient used in manufacturing of Tobramycin Inhalation Solution Pak | Tobramycin Solution, Which makes it easier to analyze its effect in breastfeeding. As per our analysis of Tobramycin it is safe to use Tobramycin Inhalation Solution Pak | Tobramycin Solution while lactating. We suggest you to check further details below about Tobramycin usage in breastfeeding.
Statement of Manufacturer/Labeler about breastfeeding usage
8.3 Nursing Mothers It is not known if tobramycin inhalation solution will reach sufficient concentrations after administration by inhalation to be excreted in human breast milk. Because of the potential for ototoxicity and nephrotoxicity in nursing infants from tobramycin inhalation solution, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
Tobramycin Inhalation Solution Pak | Tobramycin Solution Breastfeeding Analsys
SafeCAS Number: 32986-56-4
Excreted into breast milk in non-significant amount without harm effects observed among breastfed infants of mothers treated with Tobramycin. In addition, a low oral bioavailability renders concentration in the infant's plasma be nil or low. Be aware of false negative results that may be obtained from infants with bacterial cultures when the mother is on antibiotics and higher risk of acute diarrhea by alteration of normal gut flora. When used in eye drops, because of a low dose and topical application with minimal absorption in the serum, it is compatible while breastfeeding.
Tobramycin Inhalation Solution Pak | Tobramycin Solution Breastfeeding Analsys - 2
CAS Number: 32986-56-4
Tobramycin is poorly excreted into breastmilk. Newborn infants apparently absorb small amounts of other aminoglycosides, but serum levels with typical three times per day dosages are far below those attained when treating newborn infections and systemic effects of tobramycin are unlikely. Older infants would be expected to absorb even less tobramycin. Because there is little variability in the milk tobramycin levels during multiple daily dose regimens, timing breastfeeding with respect to the dose is of little or no benefit in reducing infant exposure. Data are not available with single daily dose regimens. Monitor the infant for possible effects on the gastrointestinal flora, such as diarrhea, candidiasis (e.g., thrush, diaper rash) or rarely, blood in the stool indicating possible antibiotic-associated colitis. Maternal use of an ear drop or eye drop that contains tobramycin presents little or no risk for the nursing infant [4]
What should I do if I am breastfeeding mother and I am already exposed to Tobramycin Inhalation Solution Pak | Tobramycin Solution?
It is always a good idea to keep your healthcare provider or doctor informed about your drug usage during pregnancy and breastfeeding but if you have not informed your doctor about Tobramycin Inhalation Solution Pak | Tobramycin Solution and have used it then do not panic as Tobramycin Inhalation Solution Pak | Tobramycin Solution is mostly safe in breastfeeding and should not cause any harm to your baby.
My health care provider has asked me to use Tobramycin Inhalation Solution Pak | Tobramycin Solution, what to do?
Definitely, Tobramycin Inhalation Solution Pak | Tobramycin Solution is safe in lactation for baby. No wonder your doctor has recommended it.
If I am using Tobramycin Inhalation Solution Pak | Tobramycin Solution, will my baby need extra monitoring?
No extra baby monitoring required while mother is using Tobramycin Inhalation Solution Pak | Tobramycin Solution
Who can I talk to if I have questions about usage of Tobramycin Inhalation Solution Pak | Tobramycin Solution in breastfeeding?
US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday
UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700
Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week
Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week